Meda will syndicate €3bn loan for Rottapharm deal next week
Swedish pharmaceutical company Meda has completed the early bird syndication of its Skr28bn (€3.03bn) loan to buy Rottapharm Madaus, according to a banker at one of the leads.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts